Global Intravenous Immunoglobulin Market Size, Share & Industry Trends Analysis Report By Distribution Channel (Hospital Pharmacy, Specialty Pharmacy, and Others), By Application, By Regional Outlook and Forecast, 2022 - 2028

The Global Intravenous Immunoglobulin Market size is expected to reach $17.3 billion by 2028, rising at a market growth of 6.9% CAGR during the forecast period.

Immunoglobulins are glycoprotein molecules that are produced by plasma or white blood cells. It plays a crucial role in the immune system's defense by identifying and attaching to certain antigens such as bacteria and viruses, assisting in the elimination. Intravenous immunoglobulins are immunoglobulins that are given via intravenous injection. This is because most patients receiving immunoglobulins are in hospitals or clinical settings, and intravenous immunoglobulins are the most prevalent mode of administration. This coupled with the demonstrated efficacy of the immunoglobulins as an efficient therapy choice for a number of immunological illnesses and the inadequate amount of training for home-care settings is also positively influencing the Intravenous Immunoglobulin market growth.

Several people may use IVIg instead of other medications to treat their immune system problems such as immunosuppressants, corticosteroids, or biological therapies. IVIg may be used in conjunction with immunosuppressants or other medications in some instances. The immune system of the body regularly produces enough antibodies to fight infection-causing bacteria. The body can't create enough of them if a patient has an immunological deficit. As a result, the patient is more susceptible to infections that can make a person very unwell. IVIg provides antibodies that the body doesn't produce on its own, allowing the patient to fight infections.

The medication may help the body raise low red blood-cell levels in autoimmune illnesses like lupus. If a person doesn't get enough of them, the person suffers from anaemia and weary. IVIg prevents lupus patients' white blood cells from damaging the red blood cells. The medication may stop the patient's immune system from destroying muscle cells if such a person has myositis.

COVID-19 Impact Analysis

The COVID-19 pandemic has presented both a threat and a lucrative opportunity for the IVIG business. The pandemic has also brought together a number of significant players and governments to support the development of novel COVID-19 hyper-immunoglobulins. Plasma-based medicines are being researched for their effectiveness in reducing problems due to severe acute viral respiratory infections, comprising COVID-19. This medication is derived from recovered patients' plasma. The market is likely to be driven by the pandemic, which is presently in its last phases. Many people with symptomatic secondary immunodeficiency (SID), auto-inflammatory disorders, primary immunodeficiency (PID), and C1 inhibitor deficiency were infected with the SARS-CoV-2 virus in the United Kingdom, some were hospitalized to hospitals, and few patients died.

Market Growth Factors

Growth in R&D activities in Intravenous Immunoglobulin

The medical system is witnessing the increasing immunoglobulin use, as well as a growth in the frequency of new launches and quick approval from government regulatory authorities around the world. For instance, as per the National Institutes of Health, a clinical trial to assess the safety, tolerability, and efficacy of a combination treatment regimen for coronavirus disease that includes the antiviral Remdesivir plus a highly concentrated solution of antibodies that neutralize SARS-CoV-2.The phase 3 trial, termed Inpatient Treatment with Anti-Coronavirus Immunoglobulin, or ITAC, was sponsored and funded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health.

Increase in cases of primary immunodeficiency diseases and preference for hospital treatment

Primary humoral immunodeficiency, chronic inflammatory demyelinating polyneuropathy (CIDP), idiopathic thrombocytopenic purpura (ITP), Guillain-Barre syndrome, multifocal motor neuropathy (MMN), myasthenia gravis, Kawasaki disease, hypogammaglobulinemia, chronic lymphocytic leukemia, and others are among the indications for intravenous immunoglobulins. The medical system witnessed a rise in the prevalence of primary immunodeficiency disorders (PID) over the world. In patients with lymphoproliferative diseases, it is the most frequent chronic immunological deficiency (LPDs).

Market Restraining Factors

The likeliness of blood transfused diseases

The risk of contracting a blood-borne infection from blood donors who provide IVIG infusions is very minimal. This is due to the purifying procedure used to purify given blood plasma, which aids in the destruction of infectious organisms such as bacteria and viruses. Additionally, once the purification process is completed, IVIG donations are maintained and packed in sterilized packaging. This aids in the prevention of infectious disease transmission even more. Aseptic meningitis, a kind of non-infection-related brain inflammation, is a significant side effect of IVIG therapy.

Distribution Channel Outlook

Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Specialty Pharmacy, and Others. The Speciality Pharmacy segment procured a substantial revenue share in the intravenous immunoglobulin market in 2021. This is because specialist pharmacies provide convenient treatment at home. Specialty medications are a vital and growing element of the pharmacy industry. As a result, the number of licensed specialty pharmaceuticals is fast expanding, propelling the specialty pharmacy industry forward over the forecast period.

Application Outlook

Based on Application, the market is segmented into Immunodeficiency Diseases, Chronic Inflammatory Demyelinating Polyneuropathy, Hypogammaglobulinemia, Chronic Lymphocytic Leukemia & Myasthenia Gravis, Congenital AIDS & Multifocal Motor Neuropathy, Kawasaki Disease, Guillain-Barre Syndrome, Immune thrombocytopenia (ITP), and Others. The chronic inflammatory demyelinating polyneuropathy segment garnered a significant revenue share in the intravenous immunoglobulin market in 2021. It is most commonly encountered in diabetic people. Immuno-suppressive medications, steroids, and plasmapheresis are all used in the treatment of CIDP. IVIG is a safe and effective alternative to these treatments. The market growth is aided by associated advantages such as safety, minimally invasive treatment, and user-friendly treatment options.

Intravenous Immunoglobulin Market Report Coverage

Report Attribute	Details
Market size value in 2021	USD 10.9 Billion
Market size forecast in 2028	USD 17.3 Billion
Base Year	2021
Historical Period	2018 to 2020
Forecast Period	2022 to 2028
Revenue Growth Rate	CAGR of 6.9% from 2022 to 2028
Number of Pages	209
Number of Tables	319
Report coverage	Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Companies Strategic Developments, Company Profiling
Segments covered	Application, Distribution Channel, Region
Country scope	US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria
Growth Drivers	Growth in R&D activities in Intravenous Immunoglobulin Increase in cases of primary immunodeficiency diseases and preference for hospital treatment
Restraints	The likeliness of blood transfused diseases

Regional Outlook

Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. The Asia Pacific witnessed a promising revenue share in the intravenous immunoglobulin market in 2021. As a result of increased awareness and potential chances for the acceptance of immunoglobulin-based therapies for the treatment of primary immunological deficiencies, as well as a growing geriatric population. Emerging economies, rising healthcare spending, and the rapidly expanding immunoglobulin market are all contributing to the market growth. Moreover, the rising prevalence of immunological illnesses increased awareness of intravenous and subcutaneous immunoglobulin therapy, and improved healthcare facilities are expected to drive future growth.

Free Valuable Insights: Global Intravenous Immunoglobulin Market size to reach USD 17.3 Billion by 2028

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Grifols, S.A., Takeda Pharmaceutical Company Limited, Baxter International, Inc., Biotest AG (Tiancheng International Investment Limited), LFB S.A., CSL Limited (CSL Behring), Octapharma AG, Kedrion S.p.A, and Bayer AG.

Strategies deployed in Intravenous Immunoglobulin Market

• Jan-2022: LFB came into a partnership with Kedrion, a provider of plasma-derived therapy. This partnership aimed to enable the companies to match the rising demands of the French market for immunoglobulins, drugs that are in great demand in France and across the world.
• Jul-2021: Octapharma received approval from U.S. Food and Drug Administration (FDA) for Octagam 10% [Immune Globulin Intravenous (Human). This approval would enable the first and only intravenous immunoglobulin (IVIg) to be indicated for the treatment of adult dermatomyositis, a rare immune-mediated inflammatory disease.
• Oct-2020: Grifols took over GC Pharma, a South Korean firm. This acquisition aimed to strengthen Grifols’ presence in Canada, building on a legacy of partnership in Canada’s blood system. In addition, this acquisition would reinforce the leadership and competitive gains provided by the plasma-center network. By raising the plasma collection and fractionation capacity, both companies would be able to continue ensuring that patients worldwide have safe and secure access to these life-saving plasma-derived medicines.
• Mar-2020: Takeda Pharmaceuticals received approval from China’s National Medical Products Administration (NMPA) for gut-selective biologic Entyvio (vedolizumab). This approval aimed to bring more treatment choices to clinicians and would allow more IBD patients to return to their normal daily lives.
• Dec-2019: Grifols introduced the XEMBIFY (immune globulin subcutaneous human-klhw). This product aimed to better the lives and well-being of people who suffer from serious, rare, and chronic diseases. XEMBIFY is the company’s first 20% subcutaneous immunoglobulin therapy for the treatment of patients 2 years of age and older with primary immunodeficiency (PI).

Scope of the Study

Market Segments Covered in the Report:

By Distribution Channel

• Hospital Pharmacy
• Specialty Pharmacy
• Others

By Application

• Immunodeficiency Diseases
• Chronic Inflammatory Demyelinating Polyneuropathy
• Hypogammaglobulinemia
• Chronic Lymphocytic Leukemia & Myasthenia Gravis
• Congenital AIDS & Multifocal Motor Neuropathy
• Kawasaki Disease
• Guillain-Barre Syndrome
• Immune thrombocytopenia (ITP)
• Others

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

• Grifols, S.A.
• Takeda Pharmaceutical Company Limited
• Baxter International, Inc.
• Biotest AG (Tiancheng International Investment Limited)
• LFB S.A.
• CSL Limited (CSL Behring)
• Octapharma AG
• Kedrion S.p.A
• Bayer AG

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Intravenous Immunoglobulin Market, by Distribution Channel
1.4.2 Global Intravenous Immunoglobulin Market, by Application
1.4.3 Global Intravenous Immunoglobulin Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Global Intravenous Immunoglobulin Market by Distribution Channel
3.1 Global Hospital Pharmacy Market by Region
3.2 Global Specialty Pharmacy Market by Region
3.3 Global Others Market by Region

Chapter 4. Global Intravenous Immunoglobulin Market by Application
4.1 Global Immunodeficiency Diseases Market by Region
4.2 Global Chronic Inflammatory Demyelinating Polyneuropathy Market by Region
4.3 Global Hypogammaglobulinemia Market by Region
4.4 Global Chronic Lymphocytic Leukemia & Myasthenia Gravis Market by Region
4.5 Global Congenital AIDS & Multifocal Motor Neuropathy Market by Region
4.6 Global Kawasaki Disease Market by Region
4.7 Global Guillain-Barre Syndrome Market by Region
4.8 Global Immune thrombocytopenia (ITP) Market by Region
4.9 Global Others Market by Region

Chapter 5. Global Intravenous Immunoglobulin Market by Region
5.1 North America Intravenous Immunoglobulin Market
5.1.1 North America Intravenous Immunoglobulin Market by Distribution Channel
5.1.1.1 North America Hospital Pharmacy Market by Country
5.1.1.2 North America Specialty Pharmacy Market by Country
5.1.1.3 North America Others Market by Country
5.1.2 North America Intravenous Immunoglobulin Market by Application
5.1.2.1 North America Immunodeficiency Diseases Market by Country
5.1.2.2 North America Chronic Inflammatory Demyelinating Polyneuropathy Market by Country
5.1.2.3 North America Hypogammaglobulinemia Market by Country
5.1.2.4 North America Chronic Lymphocytic Leukemia & Myasthenia Gravis Market by Country
5.1.2.5 North America Congenital AIDS & Multifocal Motor Neuropathy Market by Country
5.1.2.6 North America Kawasaki Disease Market by Country
5.1.2.7 North America Guillain-Barre Syndrome Market by Country
5.1.2.8 North America Immune thrombocytopenia (ITP) Market by Country
5.1.2.9 North America Others Market by Country
5.1.3 North America Intravenous Immunoglobulin Market by Country
5.1.3.1 US Intravenous Immunoglobulin Market
5.1.3.1.1 US Intravenous Immunoglobulin Market by Distribution Channel
5.1.3.1.2 US Intravenous Immunoglobulin Market by Application
5.1.3.2 Canada Intravenous Immunoglobulin Market
5.1.3.2.1 Canada Intravenous Immunoglobulin Market by Distribution Channel
5.1.3.2.2 Canada Intravenous Immunoglobulin Market by Application
5.1.3.3 Mexico Intravenous Immunoglobulin Market
5.1.3.3.1 Mexico Intravenous Immunoglobulin Market by Distribution Channel
5.1.3.3.2 Mexico Intravenous Immunoglobulin Market by Application
5.1.3.4 Rest of North America Intravenous Immunoglobulin Market
5.1.3.4.1 Rest of North America Intravenous Immunoglobulin Market by Distribution Channel
5.1.3.4.2 Rest of North America Intravenous Immunoglobulin Market by Application
5.2 Europe Intravenous Immunoglobulin Market
5.2.1 Europe Intravenous Immunoglobulin Market by Distribution Channel
5.2.1.1 Europe Hospital Pharmacy Market by Country
5.2.1.2 Europe Specialty Pharmacy Market by Country
5.2.1.3 Europe Others Market by Country
5.2.2 Europe Intravenous Immunoglobulin Market by Application
5.2.2.1 Europe Immunodeficiency Diseases Market by Country
5.2.2.2 Europe Chronic Inflammatory Demyelinating Polyneuropathy Market by Country
5.2.2.3 Europe Hypogammaglobulinemia Market by Country
5.2.2.4 Europe Chronic Lymphocytic Leukemia & Myasthenia Gravis Market by Country
5.2.2.5 Europe Congenital AIDS & Multifocal Motor Neuropathy Market by Country
5.2.2.6 Europe Kawasaki Disease Market by Country
5.2.2.7 Europe Guillain-Barre Syndrome Market by Country
5.2.2.8 Europe Immune thrombocytopenia (ITP) Market by Country
5.2.2.9 Europe Others Market by Country
5.2.3 Europe Intravenous Immunoglobulin Market by Country
5.2.3.1 Germany Intravenous Immunoglobulin Market
5.2.3.1.1 Germany Intravenous Immunoglobulin Market by Distribution Channel
5.2.3.1.2 Germany Intravenous Immunoglobulin Market by Application
5.2.3.2 UK Intravenous Immunoglobulin Market
5.2.3.2.1 UK Intravenous Immunoglobulin Market by Distribution Channel
5.2.3.2.2 UK Intravenous Immunoglobulin Market by Application
5.2.3.3 France Intravenous Immunoglobulin Market
5.2.3.3.1 France Intravenous Immunoglobulin Market by Distribution Channel
5.2.3.3.2 France Intravenous Immunoglobulin Market by Application
5.2.3.4 Russia Intravenous Immunoglobulin Market
5.2.3.4.1 Russia Intravenous Immunoglobulin Market by Distribution Channel
5.2.3.4.2 Russia Intravenous Immunoglobulin Market by Application
5.2.3.5 Spain Intravenous Immunoglobulin Market
5.2.3.5.1 Spain Intravenous Immunoglobulin Market by Distribution Channel
5.2.3.5.2 Spain Intravenous Immunoglobulin Market by Application
5.2.3.6 Italy Intravenous Immunoglobulin Market
5.2.3.6.1 Italy Intravenous Immunoglobulin Market by Distribution Channel
5.2.3.6.2 Italy Intravenous Immunoglobulin Market by Application
5.2.3.7 Rest of Europe Intravenous Immunoglobulin Market
5.2.3.7.1 Rest of Europe Intravenous Immunoglobulin Market by Distribution Channel
5.2.3.7.2 Rest of Europe Intravenous Immunoglobulin Market by Application
5.3 Asia Pacific Intravenous Immunoglobulin Market
5.3.1 Asia Pacific Intravenous Immunoglobulin Market by Distribution Channel
5.3.1.1 Asia Pacific Hospital Pharmacy Market by Country
5.3.1.2 Asia Pacific Specialty Pharmacy Market by Country
5.3.1.3 Asia Pacific Others Market by Country
5.3.2 Asia Pacific Intravenous Immunoglobulin Market by Application
5.3.2.1 Asia Pacific Immunodeficiency Diseases Market by Country
5.3.2.2 Asia Pacific Chronic Inflammatory Demyelinating Polyneuropathy Market by Country
5.3.2.3 Asia Pacific Hypogammaglobulinemia Market by Country
5.3.2.4 Asia Pacific Chronic Lymphocytic Leukemia & Myasthenia Gravis Market by Country
5.3.2.5 Asia Pacific Congenital AIDS & Multifocal Motor Neuropathy Market by Country
5.3.2.6 Asia Pacific Kawasaki Disease Market by Country
5.3.2.7 Asia Pacific Guillain-Barre Syndrome Market by Country
5.3.2.8 Asia Pacific Immune thrombocytopenia (ITP) Market by Country
5.3.2.9 Asia Pacific Others Market by Country
5.3.3 Asia Pacific Intravenous Immunoglobulin Market by Country
5.3.3.1 China Intravenous Immunoglobulin Market
5.3.3.1.1 China Intravenous Immunoglobulin Market by Distribution Channel
5.3.3.1.2 China Intravenous Immunoglobulin Market by Application
5.3.3.2 Japan Intravenous Immunoglobulin Market
5.3.3.2.1 Japan Intravenous Immunoglobulin Market by Distribution Channel
5.3.3.2.2 Japan Intravenous Immunoglobulin Market by Application
5.3.3.3 India Intravenous Immunoglobulin Market
5.3.3.3.1 India Intravenous Immunoglobulin Market by Distribution Channel
5.3.3.3.2 India Intravenous Immunoglobulin Market by Application
5.3.3.4 South Korea Intravenous Immunoglobulin Market
5.3.3.4.1 South Korea Intravenous Immunoglobulin Market by Distribution Channel
5.3.3.4.2 South Korea Intravenous Immunoglobulin Market by Application
5.3.3.5 Singapore Intravenous Immunoglobulin Market
5.3.3.5.1 Singapore Intravenous Immunoglobulin Market by Distribution Channel
5.3.3.5.2 Singapore Intravenous Immunoglobulin Market by Application
5.3.3.6 Malaysia Intravenous Immunoglobulin Market
5.3.3.6.1 Malaysia Intravenous Immunoglobulin Market by Distribution Channel
5.3.3.6.2 Malaysia Intravenous Immunoglobulin Market by Application
5.3.3.7 Rest of Asia Pacific Intravenous Immunoglobulin Market
5.3.3.7.1 Rest of Asia Pacific Intravenous Immunoglobulin Market by Distribution Channel
5.3.3.7.2 Rest of Asia Pacific Intravenous Immunoglobulin Market by Application
5.4 LAMEA Intravenous Immunoglobulin Market
5.4.1 LAMEA Intravenous Immunoglobulin Market by Distribution Channel
5.4.1.1 LAMEA Hospital Pharmacy Market by Country
5.4.1.2 LAMEA Specialty Pharmacy Market by Country
5.4.1.3 LAMEA Others Market by Country
5.4.2 LAMEA Intravenous Immunoglobulin Market by Application
5.4.2.1 LAMEA Immunodeficiency Diseases Market by Country
5.4.2.2 LAMEA Chronic Inflammatory Demyelinating Polyneuropathy Market by Country
5.4.2.3 LAMEA Hypogammaglobulinemia Market by Country
5.4.2.4 LAMEA Chronic Lymphocytic Leukemia & Myasthenia Gravis Market by Country
5.4.2.5 LAMEA Congenital AIDS & Multifocal Motor Neuropathy Market by Country
5.4.2.6 LAMEA Kawasaki Disease Market by Country
5.4.2.7 LAMEA Guillain-Barre Syndrome Market by Country
5.4.2.8 LAMEA Immune thrombocytopenia (ITP) Market by Country
5.4.2.9 LAMEA Others Market by Country
5.4.3 LAMEA Intravenous Immunoglobulin Market by Country
5.4.3.1 Brazil Intravenous Immunoglobulin Market
5.4.3.1.1 Brazil Intravenous Immunoglobulin Market by Distribution Channel
5.4.3.1.2 Brazil Intravenous Immunoglobulin Market by Application
5.4.3.2 Argentina Intravenous Immunoglobulin Market
5.4.3.2.1 Argentina Intravenous Immunoglobulin Market by Distribution Channel
5.4.3.2.2 Argentina Intravenous Immunoglobulin Market by Application
5.4.3.3 UAE Intravenous Immunoglobulin Market
5.4.3.3.1 UAE Intravenous Immunoglobulin Market by Distribution Channel
5.4.3.3.2 UAE Intravenous Immunoglobulin Market by Application
5.4.3.4 Saudi Arabia Intravenous Immunoglobulin Market
5.4.3.4.1 Saudi Arabia Intravenous Immunoglobulin Market by Distribution Channel
5.4.3.4.2 Saudi Arabia Intravenous Immunoglobulin Market by Application
5.4.3.5 South Africa Intravenous Immunoglobulin Market
5.4.3.5.1 South Africa Intravenous Immunoglobulin Market by Distribution Channel
5.4.3.5.2 South Africa Intravenous Immunoglobulin Market by Application
5.4.3.6 Nigeria Intravenous Immunoglobulin Market
5.4.3.6.1 Nigeria Intravenous Immunoglobulin Market by Distribution Channel
5.4.3.6.2 Nigeria Intravenous Immunoglobulin Market by Application
5.4.3.7 Rest of LAMEA Intravenous Immunoglobulin Market
5.4.3.7.1 Rest of LAMEA Intravenous Immunoglobulin Market by Distribution Channel
5.4.3.7.2 Rest of LAMEA Intravenous Immunoglobulin Market by Application

Chapter 6. Company Profiles
6.1 Grifols, S.A
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Regional & Segmental Analysis
6.1.4 Research & Development Expenses
6.1.5 Recent strategies and developments:
6.1.5.1 Product Launches and Product Expansions:
6.1.5.2 Acquisition and Mergers:
6.2 Takeda Pharmaceutical Company Limited
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Regional Analysis
6.2.4 Research & Development Expense
6.2.5 Recent strategies and developments:
6.2.5.1 Approvals and Trials:
6.3 Baxter International, Inc.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Regional Analysis
6.3.4 Research & Development Expense
6.4 Biotest AG (Tiancheng International Investment Limited)
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expense
6.5 LFB S.A.
6.5.1 Company Overview
6.5.2 Recent strategies and developments:
6.5.2.1 Partnerships, Collaborations, and Agreements:
6.6 CSL Limited (CSL Behring)
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.7 Octapharma AG
6.7.1 Company Overview
6.7.2 Recent strategies and developments:
6.7.2.1 Approvals and Trials:
6.8 Kedrion S.p.A
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.8.4 Research & Development Expenses
6.9 Bayer AG
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Segmental and Regional Analysis
6.9.4 Research & Development Expense

TABLE 1 Global Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
TABLE 2 Global Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
TABLE 3 Global Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 4 Global Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 5 Global Hospital Pharmacy Market by Region, 2018 - 2021, USD Million
TABLE 6 Global Hospital Pharmacy Market by Region, 2022 - 2028, USD Million
TABLE 7 Global Specialty Pharmacy Market by Region, 2018 - 2021, USD Million
TABLE 8 Global Specialty Pharmacy Market by Region, 2022 - 2028, USD Million
TABLE 9 Global Others Market by Region, 2018 - 2021, USD Million
TABLE 10 Global Others Market by Region, 2022 - 2028, USD Million
TABLE 11 Global Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
TABLE 12 Global Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
TABLE 13 Global Immunodeficiency Diseases Market by Region, 2018 - 2021, USD Million
TABLE 14 Global Immunodeficiency Diseases Market by Region, 2022 - 2028, USD Million
TABLE 15 Global Chronic Inflammatory Demyelinating Polyneuropathy Market by Region, 2018 - 2021, USD Million
TABLE 16 Global Chronic Inflammatory Demyelinating Polyneuropathy Market by Region, 2022 - 2028, USD Million
TABLE 17 Global Hypogammaglobulinemia Market by Region, 2018 - 2021, USD Million
TABLE 18 Global Hypogammaglobulinemia Market by Region, 2022 - 2028, USD Million
TABLE 19 Global Chronic Lymphocytic Leukemia & Myasthenia Gravis Market by Region, 2018 - 2021, USD Million
TABLE 20 Global Chronic Lymphocytic Leukemia & Myasthenia Gravis Market by Region, 2022 - 2028, USD Million
TABLE 21 Global Congenital AIDS & Multifocal Motor Neuropathy Market by Region, 2018 - 2021, USD Million
TABLE 22 Global Congenital AIDS & Multifocal Motor Neuropathy Market by Region, 2022 - 2028, USD Million
TABLE 23 Global Kawasaki Disease Market by Region, 2018 - 2021, USD Million
TABLE 24 Global Kawasaki Disease Market by Region, 2022 - 2028, USD Million
TABLE 25 Global Guillain-Barre Syndrome Market by Region, 2018 - 2021, USD Million
TABLE 26 Global Guillain-Barre Syndrome Market by Region, 2022 - 2028, USD Million
TABLE 27 Global Immune thrombocytopenia (ITP) Market by Region, 2018 - 2021, USD Million
TABLE 28 Global Immune thrombocytopenia (ITP) Market by Region, 2022 - 2028, USD Million
TABLE 29 Global Others Market by Region, 2018 - 2021, USD Million
TABLE 30 Global Others Market by Region, 2022 - 2028, USD Million
TABLE 31 Global Intravenous Immunoglobulin Market by Region, 2018 - 2021, USD Million
TABLE 32 Global Intravenous Immunoglobulin Market by Region, 2022 - 2028, USD Million
TABLE 33 North America Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
TABLE 34 North America Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
TABLE 35 North America Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 36 North America Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 37 North America Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 38 North America Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 39 North America Specialty Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 40 North America Specialty Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 41 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 42 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 43 North America Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
TABLE 44 North America Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
TABLE 45 North America Immunodeficiency Diseases Market by Country, 2018 - 2021, USD Million
TABLE 46 North America Immunodeficiency Diseases Market by Country, 2022 - 2028, USD Million
TABLE 47 North America Chronic Inflammatory Demyelinating Polyneuropathy Market by Country, 2018 - 2021, USD Million
TABLE 48 North America Chronic Inflammatory Demyelinating Polyneuropathy Market by Country, 2022 - 2028, USD Million
TABLE 49 North America Hypogammaglobulinemia Market by Country, 2018 - 2021, USD Million
TABLE 50 North America Hypogammaglobulinemia Market by Country, 2022 - 2028, USD Million
TABLE 51 North America Chronic Lymphocytic Leukemia & Myasthenia Gravis Market by Country, 2018 - 2021, USD Million
TABLE 52 North America Chronic Lymphocytic Leukemia & Myasthenia Gravis Market by Country, 2022 - 2028, USD Million
TABLE 53 North America Congenital AIDS & Multifocal Motor Neuropathy Market by Country, 2018 - 2021, USD Million
TABLE 54 North America Congenital AIDS & Multifocal Motor Neuropathy Market by Country, 2022 - 2028, USD Million
TABLE 55 North America Kawasaki Disease Market by Country, 2018 - 2021, USD Million
TABLE 56 North America Kawasaki Disease Market by Country, 2022 - 2028, USD Million
TABLE 57 North America Guillain-Barre Syndrome Market by Country, 2018 - 2021, USD Million
TABLE 58 North America Guillain-Barre Syndrome Market by Country, 2022 - 2028, USD Million
TABLE 59 North America Immune thrombocytopenia (ITP) Market by Country, 2018 - 2021, USD Million
TABLE 60 North America Immune thrombocytopenia (ITP) Market by Country, 2022 - 2028, USD Million
TABLE 61 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 62 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 63 North America Intravenous Immunoglobulin Market by Country, 2018 - 2021, USD Million
TABLE 64 North America Intravenous Immunoglobulin Market by Country, 2022 - 2028, USD Million
TABLE 65 US Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
TABLE 66 US Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
TABLE 67 US Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 68 US Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 69 US Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
TABLE 70 US Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
TABLE 71 Canada Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
TABLE 72 Canada Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
TABLE 73 Canada Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 74 Canada Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 75 Canada Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
TABLE 76 Canada Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
TABLE 77 Mexico Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
TABLE 78 Mexico Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
TABLE 79 Mexico Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 80 Mexico Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 81 Mexico Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
TABLE 82 Mexico Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
TABLE 83 Rest of North America Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
TABLE 84 Rest of North America Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
TABLE 85 Rest of North America Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 86 Rest of North America Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 87 Rest of North America Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
TABLE 88 Rest of North America Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
TABLE 89 Europe Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
TABLE 90 Europe Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
TABLE 91 Europe Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 92 Europe Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 93 Europe Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 94 Europe Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 95 Europe Specialty Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 96 Europe Specialty Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 97 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 98 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 99 Europe Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
TABLE 100 Europe Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
TABLE 101 Europe Immunodeficiency Diseases Market by Country, 2018 - 2021, USD Million
TABLE 102 Europe Immunodeficiency Diseases Market by Country, 2022 - 2028, USD Million
TABLE 103 Europe Chronic Inflammatory Demyelinating Polyneuropathy Market by Country, 2018 - 2021, USD Million
TABLE 104 Europe Chronic Inflammatory Demyelinating Polyneuropathy Market by Country, 2022 - 2028, USD Million
TABLE 105 Europe Hypogammaglobulinemia Market by Country, 2018 - 2021, USD Million
TABLE 106 Europe Hypogammaglobulinemia Market by Country, 2022 - 2028, USD Million
TABLE 107 Europe Chronic Lymphocytic Leukemia & Myasthenia Gravis Market by Country, 2018 - 2021, USD Million
TABLE 108 Europe Chronic Lymphocytic Leukemia & Myasthenia Gravis Market by Country, 2022 - 2028, USD Million
TABLE 109 Europe Congenital AIDS & Multifocal Motor Neuropathy Market by Country, 2018 - 2021, USD Million
TABLE 110 Europe Congenital AIDS & Multifocal Motor Neuropathy Market by Country, 2022 - 2028, USD Million
TABLE 111 Europe Kawasaki Disease Market by Country, 2018 - 2021, USD Million
TABLE 112 Europe Kawasaki Disease Market by Country, 2022 - 2028, USD Million
TABLE 113 Europe Guillain-Barre Syndrome Market by Country, 2018 - 2021, USD Million
TABLE 114 Europe Guillain-Barre Syndrome Market by Country, 2022 - 2028, USD Million
TABLE 115 Europe Immune thrombocytopenia (ITP) Market by Country, 2018 - 2021, USD Million
TABLE 116 Europe Immune thrombocytopenia (ITP) Market by Country, 2022 - 2028, USD Million
TABLE 117 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 118 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 119 Europe Intravenous Immunoglobulin Market by Country, 2018 - 2021, USD Million
TABLE 120 Europe Intravenous Immunoglobulin Market by Country, 2022 - 2028, USD Million
TABLE 121 Germany Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
TABLE 122 Germany Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
TABLE 123 Germany Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 124 Germany Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 125 Germany Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
TABLE 126 Germany Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
TABLE 127 UK Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
TABLE 128 UK Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
TABLE 129 UK Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 130 UK Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 131 UK Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
TABLE 132 UK Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
TABLE 133 France Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
TABLE 134 France Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
TABLE 135 France Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 136 France Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 137 France Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
TABLE 138 France Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
TABLE 139 Russia Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
TABLE 140 Russia Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
TABLE 141 Russia Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 142 Russia Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 143 Russia Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
TABLE 144 Russia Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
TABLE 145 Spain Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
TABLE 146 Spain Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
TABLE 147 Spain Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 148 Spain Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 149 Spain Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
TABLE 150 Spain Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
TABLE 151 Italy Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
TABLE 152 Italy Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
TABLE 153 Italy Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 154 Italy Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 155 Italy Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
TABLE 156 Italy Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
TABLE 157 Rest of Europe Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
TABLE 158 Rest of Europe Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
TABLE 159 Rest of Europe Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 160 Rest of Europe Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 161 Rest of Europe Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
TABLE 162 Rest of Europe Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
TABLE 163 Asia Pacific Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
TABLE 164 Asia Pacific Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
TABLE 165 Asia Pacific Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 166 Asia Pacific Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 167 Asia Pacific Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 168 Asia Pacific Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 169 Asia Pacific Specialty Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 170 Asia Pacific Specialty Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 171 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 172 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 173 Asia Pacific Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
TABLE 174 Asia Pacific Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
TABLE 175 Asia Pacific Immunodeficiency Diseases Market by Country, 2018 - 2021, USD Million
TABLE 176 Asia Pacific Immunodeficiency Diseases Market by Country, 2022 - 2028, USD Million
TABLE 177 Asia Pacific Chronic Inflammatory Demyelinating Polyneuropathy Market by Country, 2018 - 2021, USD Million
TABLE 178 Asia Pacific Chronic Inflammatory Demyelinating Polyneuropathy Market by Country, 2022 - 2028, USD Million
TABLE 179 Asia Pacific Hypogammaglobulinemia Market by Country, 2018 - 2021, USD Million
TABLE 180 Asia Pacific Hypogammaglobulinemia Market by Country, 2022 - 2028, USD Million
TABLE 181 Asia Pacific Chronic Lymphocytic Leukemia & Myasthenia Gravis Market by Country, 2018 - 2021, USD Million
TABLE 182 Asia Pacific Chronic Lymphocytic Leukemia & Myasthenia Gravis Market by Country, 2022 - 2028, USD Million
TABLE 183 Asia Pacific Congenital AIDS & Multifocal Motor Neuropathy Market by Country, 2018 - 2021, USD Million
TABLE 184 Asia Pacific Congenital AIDS & Multifocal Motor Neuropathy Market by Country, 2022 - 2028, USD Million
TABLE 185 Asia Pacific Kawasaki Disease Market by Country, 2018 - 2021, USD Million
TABLE 186 Asia Pacific Kawasaki Disease Market by Country, 2022 - 2028, USD Million
TABLE 187 Asia Pacific Guillain-Barre Syndrome Market by Country, 2018 - 2021, USD Million
TABLE 188 Asia Pacific Guillain-Barre Syndrome Market by Country, 2022 - 2028, USD Million
TABLE 189 Asia Pacific Immune thrombocytopenia (ITP) Market by Country, 2018 - 2021, USD Million
TABLE 190 Asia Pacific Immune thrombocytopenia (ITP) Market by Country, 2022 - 2028, USD Million
TABLE 191 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 192 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 193 Asia Pacific Intravenous Immunoglobulin Market by Country, 2018 - 2021, USD Million
TABLE 194 Asia Pacific Intravenous Immunoglobulin Market by Country, 2022 - 2028, USD Million
TABLE 195 China Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
TABLE 196 China Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
TABLE 197 China Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 198 China Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 199 China Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
TABLE 200 China Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
TABLE 201 Japan Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
TABLE 202 Japan Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
TABLE 203 Japan Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 204 Japan Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 205 Japan Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
TABLE 206 Japan Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
TABLE 207 India Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
TABLE 208 India Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
TABLE 209 India Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 210 India Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 211 India Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
TABLE 212 India Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
TABLE 213 South Korea Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
TABLE 214 South Korea Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
TABLE 215 South Korea Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 216 South Korea Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 217 South Korea Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
TABLE 218 South Korea Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
TABLE 219 Singapore Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
TABLE 220 Singapore Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
TABLE 221 Singapore Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 222 Singapore Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 223 Singapore Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
TABLE 224 Singapore Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
TABLE 225 Malaysia Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
TABLE 226 Malaysia Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
TABLE 227 Malaysia Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 228 Malaysia Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 229 Malaysia Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
TABLE 230 Malaysia Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
TABLE 231 Rest of Asia Pacific Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
TABLE 232 Rest of Asia Pacific Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
TABLE 233 Rest of Asia Pacific Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 234 Rest of Asia Pacific Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 235 Rest of Asia Pacific Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
TABLE 236 Rest of Asia Pacific Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
TABLE 237 LAMEA Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
TABLE 238 LAMEA Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
TABLE 239 LAMEA Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 240 LAMEA Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 241 LAMEA Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 242 LAMEA Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 243 LAMEA Specialty Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 244 LAMEA Specialty Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 245 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 246 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 247 LAMEA Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
TABLE 248 LAMEA Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
TABLE 249 LAMEA Immunodeficiency Diseases Market by Country, 2018 - 2021, USD Million
TABLE 250 LAMEA Immunodeficiency Diseases Market by Country, 2022 - 2028, USD Million
TABLE 251 LAMEA Chronic Inflammatory Demyelinating Polyneuropathy Market by Country, 2018 - 2021, USD Million
TABLE 252 LAMEA Chronic Inflammatory Demyelinating Polyneuropathy Market by Country, 2022 - 2028, USD Million
TABLE 253 LAMEA Hypogammaglobulinemia Market by Country, 2018 - 2021, USD Million
TABLE 254 LAMEA Hypogammaglobulinemia Market by Country, 2022 - 2028, USD Million
TABLE 255 LAMEA Chronic Lymphocytic Leukemia & Myasthenia Gravis Market by Country, 2018 - 2021, USD Million
TABLE 256 LAMEA Chronic Lymphocytic Leukemia & Myasthenia Gravis Market by Country, 2022 - 2028, USD Million
TABLE 257 LAMEA Congenital AIDS & Multifocal Motor Neuropathy Market by Country, 2018 - 2021, USD Million
TABLE 258 LAMEA Congenital AIDS & Multifocal Motor Neuropathy Market by Country, 2022 - 2028, USD Million
TABLE 259 LAMEA Kawasaki Disease Market by Country, 2018 - 2021, USD Million
TABLE 260 LAMEA Kawasaki Disease Market by Country, 2022 - 2028, USD Million
TABLE 261 LAMEA Guillain-Barre Syndrome Market by Country, 2018 - 2021, USD Million
TABLE 262 LAMEA Guillain-Barre Syndrome Market by Country, 2022 - 2028, USD Million
TABLE 263 LAMEA Immune thrombocytopenia (ITP) Market by Country, 2018 - 2021, USD Million
TABLE 264 LAMEA Immune thrombocytopenia (ITP) Market by Country, 2022 - 2028, USD Million
TABLE 265 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 266 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 267 LAMEA Intravenous Immunoglobulin Market by Country, 2018 - 2021, USD Million
TABLE 268 LAMEA Intravenous Immunoglobulin Market by Country, 2022 - 2028, USD Million
TABLE 269 Brazil Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
TABLE 270 Brazil Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
TABLE 271 Brazil Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 272 Brazil Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 273 Brazil Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
TABLE 274 Brazil Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
TABLE 275 Argentina Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
TABLE 276 Argentina Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
TABLE 277 Argentina Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 278 Argentina Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 279 Argentina Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
TABLE 280 Argentina Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
TABLE 281 UAE Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
TABLE 282 UAE Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
TABLE 283 UAE Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 284 UAE Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 285 UAE Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
TABLE 286 UAE Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
TABLE 287 Saudi Arabia Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
TABLE 288 Saudi Arabia Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
TABLE 289 Saudi Arabia Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 290 Saudi Arabia Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 291 Saudi Arabia Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
TABLE 292 Saudi Arabia Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
TABLE 293 South Africa Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
TABLE 294 South Africa Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
TABLE 295 South Africa Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 296 South Africa Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 297 South Africa Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
TABLE 298 South Africa Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
TABLE 299 Nigeria Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
TABLE 300 Nigeria Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
TABLE 301 Nigeria Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 302 Nigeria Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 303 Nigeria Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
TABLE 304 Nigeria Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
TABLE 305 Rest of LAMEA Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
TABLE 306 Rest of LAMEA Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
TABLE 307 Rest of LAMEA Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 308 Rest of LAMEA Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 309 Rest of LAMEA Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
TABLE 310 Rest of LAMEA Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
TABLE 311 Key information – Grifols, S.A.
TABLE 312 Key Information – Takeda Pharmaceutical Company Limited
TABLE 313 Key Information – Baxter International, Inc.
TABLE 314 key information – Biotest AG
TABLE 315 Key Information – LFB S.A
TABLE 316 key Information – CSL Limited
TABLE 317 Key Information – Octapharma AG
TABLE 318 key Information – Kedrion S.p.A
TABLE 319 Key Information – Bayer AG

List of Figures
FIG 1 Methodology for the research
FIG 2 Global Intravenous Immunoglobulin Market share by Distribution Channel, 2021
FIG 3 Global Intravenous Immunoglobulin Market share by Distribution Channel, 2028
FIG 4 Global Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2028, USD Million
FIG 5 Global Intravenous Immunoglobulin Market share by Application, 2021
FIG 6 Global Intravenous Immunoglobulin Market share by Application, 2028
FIG 7 Global Intravenous Immunoglobulin Market by Application, 2018 - 2028, USD Million
FIG 8 Global Intravenous Immunoglobulin Market share by Region, 2021
FIG 9 Global Intravenous Immunoglobulin Market share by Region, 2028
FIG 10 Global Intravenous Immunoglobulin Market by Region, 2018 - 2028, USD Million
FIG 11 Recent strategies and developments: Grifols, S.A.